Nicardipine Hydrochloride Injection
Product Images NDC 70069-875

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride (NDC 70069-875). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicardipine-20mg-200ml-alu-pouch-label (Nicardipine 20mg 200ml Alu Pouch Label)

Nicardipine-20mg-200ml-alu-pouch-label (Nicardipine 20mg 200ml Alu Pouch Label)
This text appears to be a description of a pharmaceutical product. It is Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection, with a concentration of 20 mg in 200 mL (0.1 mg/mL). The product is intended for intravenous infusion and is provided in a single-dose container. The dosage details are included in the Prescribing Information. The text also mentions storage instructions, cautions regarding usage, and manufacturing details. Additionally, it emphasizes the need to discard any unused portion of the solution.*
FDA Label Image

Nicardipine-20mg-200ml-bag-label (Nicardipine 20mg 200ml Bag Label)

Nicardipine-20mg-200ml-bag-label (Nicardipine 20mg 200ml Bag Label)
This is a detailed description of a medication labeled as Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection, meant for intravenous infusion. The dosage strength is 20 mg in 200 mL, equivalent to 0.1 mg/mL. The product is sterile, nonpyrogenic, and should be used immediately upon removal from the overwrap. It contains 0.1 mg Nicardipine Hydrochloride USP in 9 mg Sodium Chloride USP per mL, with a pH adjusted to 3 to 5 using hydrochloric acid. The packaging is a 200 mL iso-osmotic single-dose container, and any unused portion should be discarded. The product is manufactured by Somerset Therapeutics, LLC in India. Storage instructions include storing at 20° to 25°C, protecting from light, and avoiding excessive heat. The label also cautions to check for leaks, not to use cloudy solutions, not to add additional medication, and not to use in series connections. The final information includes the batch coding area size, product code, and manufacturer details.*
FDA Label Image

Nicardipine-40mg-200ml-alu-pouch-label (Nicardipine 40mg 200ml Alu Pouch Label)

Nicardipine-40mg-200ml-alu-pouch-label (Nicardipine 40mg 200ml Alu Pouch Label)
This is information about Nicardipine Hydrochloride in Sodium Chloride Injection, provided in a 200mL iso-osmotic solution for intravenous infusion. It contains 40mg of Nicardipine Hydrochloride per 200mL, with a concentration of 0.2mg/mL. The solution is sterile and nonpyrogenic. Each mL also contains 9mg of Sodium Chloride. It is advised to check the infusion rate due to its double concentration. The pH is adjusted to 3 to 5 using Hydrochloric Acid. Storage instructions include keeping it between 20° to 25°C and protecting from light. The container is for single-dose, and any unused portion should be discarded. Care must be taken to avoid leaks, and the solution should be clear before use. No additional medications should be added, and it should not be used in series connections. For complete information on dosage and administration, prescribing information should be consulted.*
FDA Label Image

Nicardipine-40mg-200ml-bag-label (Nicardipine 40mg 200ml Bag Label)

Nicardipine-40mg-200ml-bag-label (Nicardipine 40mg 200ml Bag Label)
This description provides details about a medication product named Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection. It includes information on dosage, administration, storage instructions, manufacturer details, and warnings such as checking for leaks, clear solution requirement, and avoiding series connections. The product comes in a 200mL container that should be used immediately after removal from the overwrap and discarded if any portion is unused.*
FDA Label Image

Nicardipine-structure (Nicardipine Structure)

FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.